Literature DB >> 2502793

Effects of prior saline-morphine discrimination by pigeons on three-way discrimination including two morphine doses.

D V Gauvin1, A M Young.   

Abstract

The discriminative stimulus properties of morphine sulfate (MS) and their alteration by naltrexone (NTX) and d-amphetamine (AMP) challenges were examined in a quantitative dose 1, dose 2, and saline (SAL) drug discrimination task utilizing 1.8 mg/kg MS, 10 mg/kg MS, and SAL as discriminative stimuli under a fixed-ratio 30 schedule of food-maintained behavior in two groups of White Carneaux pigeons. Group A (Gp A) (n = 6) subjects (Ss) were initially experimentally- and drug-naive, whereas group B Ss (n = 4) were originally trained in a two-choice MS versus SAL discrimination task, and had a long behavioral and drug history. Significant differences were found in (1) number of sessions to criterion (STC) (group B greater than group A); (2) group A Ss generalized both NTX and AMP to SAL, whereas group B Ss generalized AMP to the low dose (1.8 mg/kg) MS stimulus; and (3) in drug interaction test sessions, the high dose MS stimulus (10 mg/kg) in group A was unmodified by a range of challenge AMP doses (0.32 to 3.2 mg/kg). In contrast, group B Ss exhibited a shift to the low dose or SAL-appropriate keys when the same high dose MS stimulus was challenged by moderate doses of AMP. Group A and group B were similar in their pattern and distribution of responses when tested with various doses of MS, and also when challenge tests of the high dose MS stimulus were made with NTX.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502793     DOI: 10.1007/bf00444695

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

Review 1.  Opioid antagonists.

Authors:  W R Martin
Journal:  Pharmacol Rev       Date:  1967-12       Impact factor: 25.468

2.  Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.

Authors:  J M White; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

Review 3.  Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions.

Authors:  S Herling; J H Woods
Journal:  Life Sci       Date:  1981-04-06       Impact factor: 5.037

4.  Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.

Authors:  C P France; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1985-07       Impact factor: 4.030

5.  Narcotic discrimination in pigeons.

Authors:  S Herling; E H Coale; R J Valentino; D W Hein; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1980-07       Impact factor: 4.030

6.  Evidence for perceptual masking of the discriminative morphine stimulus.

Authors:  D V Gauvin; A M Young
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Narcotic discrimination in pigeons: antagonism by naltrexone.

Authors:  S Herling; R J Valentino; R E Solomon; J H Woods
Journal:  Eur J Pharmacol       Date:  1984-10-01       Impact factor: 4.432

8.  Stimulus properties of opioids with mixed agonist and antagonist activity.

Authors:  S G Holtzman
Journal:  Fed Proc       Date:  1982-05

9.  Drug discrimination training with progressively lowered doses.

Authors:  D A Overton
Journal:  Science       Date:  1979-08-17       Impact factor: 47.728

10.  Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids.

Authors:  J M White; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more
  2 in total

1.  Tolerance to morphine stimulus control: role of morphine maintenance dose.

Authors:  A M Young; C A Sannerud; E S Steigerwald; M D Doty; W J Lipinski; L E Tetrick
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Evidence for perceptual masking of the discriminative morphine stimulus.

Authors:  D V Gauvin; A M Young
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.